Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in England

Despite the availability of the ChAdOx1-S booster vaccine, little is known about the real-world effectiveness although clinical trials have demonstrated enhanced immunity following a ChAdOx1-S booster. In England 43,171 individuals received a ChAdOx1-S booster whilst 13,038,908 individuals received...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirsebom, Freja Cordelia Møller, Andrews, Nick, Sachdeva, Ruchira, Stowe, Julia, Ramsay, Mary, Lopez Bernal, Jamie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744366/
https://www.ncbi.nlm.nih.gov/pubmed/36509743
http://dx.doi.org/10.1038/s41467-022-35168-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744366/
https://www.ncbi.nlm.nih.gov/pubmed/36509743
http://dx.doi.org/10.1038/s41467-022-35168-7

Ejemplares similares